¼¼°èÀÇ ¸· Å©·Î¸¶Åä±×·¡ÇÇ ½ÃÀå - ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : Á¦Ç°º°, ¼ö¹ýº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°, ºÎ¹® ¿¹Ãø(2025-2030³â)
Membrane Chromatography Market Size, Share & Trends Analysis Report By Product (Capsules Cassette & Cartridges, Syringe Filters, Membrane Filters), By Technique, By End Use, By Region, And Segment Forecasts, 2025 - 2030
»óǰÄÚµå : 1654204
¸®¼­Ä¡»ç : Grand View Research, Inc.
¹ßÇàÀÏ : 2025³â 01¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 100 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,950 £Ü 8,515,000
Unprintable PDF & Excel (Single User License) help
º¸°í¼­ PDF ¹× ¿¢¼¿À» 1Àθ¸ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, Àμâ´Â ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 6,950 £Ü 9,946,000
Printable PDF & Excel (5-User License) help
º¸°í¼­ PDF ¹× ¿¢¼¿À» µ¿ÀÏ ±â¾÷ ³» µ¿ÀÏ ºÎ¼­¿¡¼­ ÃÖ´ë 5¸í±îÁö »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, Àμâ´Â °¡´ÉÇÕ´Ï´Ù.
US $ 8,950 £Ü 12,809,000
Printable PDF & Excel (Enterprise License) help
º¸°í¼­ ±¸¸Å ±â¾÷ ¹× ±× ÀÚȸ»ç, °ü°è»ç°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀ̸ç, PDF ¹× ¿¢¼¿ ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, ÀμⰡ °¡´ÉÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¸· Å©·Î¸¶Åä±×·¡ÇÇ ½ÃÀå µ¿Çâ

¸· Å©·Î¸¶Åä±×·¡ÇÇ ¼¼°è ½ÃÀå ±Ô¸ð´Â 2024³â¿¡ 3¾ï 2,440¸¸ ´Þ·¯·Î ÃßÁ¤µÇ¾úÀ¸¸ç, 2025-2030³â µ¿¾È CAGR 16.0%¸¦ ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¸· Å©·Î¸¶Åä±×·¡ÇÇ ½ÃÀåÀº ÁÖ·Î ¹ÙÀÌ¿À ÀǾàǰ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿Í ÇÏ·ù Á¤È­ °øÁ¤¿¡¼­ ¼¼Ã´ °ËÁõ¿¡ ´ëÇÑ ±ÔÁ¦ Áõ°¡¿¡ ÀÇÇØ °­·ÂÇÑ ¼ºÀåÀ» ÀÌ·ç°í ÀÖ½À´Ï´Ù. ¹ÙÀÌ¿À ÀǾàǰÀÇ Á¤Á¦°¡ ´õ¿í ¾ö°ÝÇØÁü¿¡ µû¶ó È¿À²ÀûÀÌ°í ºñ¿ë È¿À²ÀûÀÎ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¿ä±¸°¡ Ä¿Áö°í ¸· Å©·Î¸¶Åä±×·¡ÇÇ »ç¿ëÀÌ ±ÞÁõÇϰí ÀÖ½À´Ï´Ù. ÀÌ ±â¼úÀº ±âÁ¸ÀÇ Ä÷³ Å©·Î¸¶Åä±×·¡ÇÇ¿¡ ºñÇØ ³ôÀº °áÇÕ ¿ë·®°ú ¿ÏÃæ¾× ¼Òºñ¸¦ ÁÙÀÌ´Â µî ¹ÙÀÌ¿À ÀǾàǰ Á¦Á¶ ÃÖÀûÈ­¿¡ ÇʼöÀûÀÎ Å« ÀÌÁ¡À» ¼³¸íÇÕ´Ï´Ù.

È®À强°ú »ç¿ë ÆíÀǼºÀÌ ¸· Å©·Î¸¶Åä±×·¡ÇÇÀÇ ¸Å·ÂÀ» ´õ¿í Çâ»ó½Ã۰í ÀÖÀ¸¸ç, ƯÈ÷ ´ÜŬ·ÐÇ×ü³ª ¹ÙÀÌ·¯½º º¤ÅÍ µî Ä¡·á³ª ¹é½Å Á¦Á¶¿¡ ÇʼöÀûÀÎ ´ëÇü »ýüºÐÀÚ¿¡ ÀûÇÕÇÕ´Ï´Ù. »ý¹° Á¦Á¦ ¼ö¿ä Áõ°¡´Â ¼øµµ¿Í ¾ÈÀü¼º¿¡ ´ëÇÑ ¾ö°ÝÇÑ ±ÔÁ¦ ±âÁØÀ» ÅëÇØ ¹ÙÀÌ¿ÀÇÁ·Î¼¼½º »ê¾÷ ±â¾÷¿¡ ¸· Å©·Î¸¶Åä±×·¡ÇÇ¿Í °°Àº °í±Þ Á¤Á¦ ±â¼úÀ» äÅÃÇϵµ·Ï Ã˱¸Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¯È­´Â ¹ÙÀÌ¿À ÀǾàǰ ½ÃÀåÀÇ »ó´çÇÑ ¼ºÀåÀÌ ¿¹»óµÇ°í ǰÁú°ú ÄÄÇöóÀ̾𽺸¦ À¯ÁöÇϱâ À§ÇØ Çõ½ÅÀûÀÎ Á¤Á¦ ¹æ¹ýÀÌ ÇÊ¿äÇÏ´Ù´Â °ÍÀ» º¸¿©ÁÖ´Â ¿¹ÃøÀ¸·Î µÞ¹ÞħµË´Ï´Ù.

¹ÙÀÌ¿À ÀǾàǰ Á¦Á¶¿¡ °üÇÑ ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀεµ ½ÃÀå ¼ºÀåÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2024³â 4¿ù, Boehringer Ingelheim Biopharmaceuticals China´Â À¯·´ ÀǾàû°ú ¹Ì±¹ ½ÄǰÀǾ౹ÀÌ ½Ç½ÃÇÑ ½ÂÀÎ Àü °Ë»ç¸¦ Åë°úÇÏ´Â µ¥ ¼º°øÇß½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÇÀûÀº ±ÔÁ¦ ´ç±¹ÀÇ ¿ä±¸¿¡ ºÎÀÀÇÏ´Â ±â¾÷ÀÇ ´É·ÂÀ» ºÎ°¢½Ã۰í Á¤Á¦ ±â¼ú¿¡ ´ëÇÑ Ãß°¡ ÅõÀÚ¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ´Ù¾çÇÑ º´Å¿¡ ´ëÀÀÇÏ´Â ¹ÙÀÌ¿À ÀǾàǰ¿¡ ´ëÇÑ ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎÀÌ ÁøÇàµÊ¿¡ µû¶ó, ¸· Å©·Î¸¶Åä±×·¡ÇÇ ¼ö¿ä´Â Áõ°¡ÀÇ ±æÀ» µû¶ó°¡°í ÀÖ½À´Ï´Ù.

±ÔÁ¦ ¿äÀÎ ¿Ü¿¡µµ ¹ÙÀÌ¿À ÀǾàǰ ºÎ¹®ÀÇ ¿Õ¼ºÇÑ R&D ºñ¿ëÀÌ ½ÃÀå È®´ë¸¦ µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ±¹Á¦Á¦¾à´Üü¿¬ÇÕȸ(International Federation of Pharmaceutical Manufacturers & Associations)ÀÇ º¸°í¿¡ µû¸£¸é ¹ÙÀÌ¿ÀÀǾàǰ»ê¾÷ÀÇ ¿¬°£ ¿¬±¸°³¹ßºñ´Â 2,020¾ï ´Þ·¯¸¦ ³Ñ¾î Ç×°ø¿ìÁÖ³ª ¹æÀ§ µîÀÇ ºÎ¹®À» 7.3¹è³ª Å©°Ô ¿ôµ¹°í ÀÖ½À´Ï´Ù. ÀÌ µ¿ÇâÀº ÀÌ »ê¾÷ÀÇ ±â¼ú Çõ½Å¿¡ ´ëÇÑ Çå½ÅÀ» µÞ¹ÞħÇÏ´Â °ÍÀ¸·Î, ¿öÅͽº ÄÚÆÛ·¹À̼ÇÀÌ 2023³â 8¿ù¿¡ À¯ÀüÀÚ Ä¡·á ¿ëµµ¿¡ ƯȭÇÑ XBridge Premier GTx BEH SEC Ä÷³À» µµÀÔÇÏ´Â µî Á¦Ç°ÀÇ ¹ß¸Å¼ö°¡ Áõ°¡Çϰí ÀÖÀ½À» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Çõ½ÅÀº ¸· Å©·Î¸¶Åä±×·¡Çǰ¡ ¹ÙÀÌ¿À ÀǾàǰ »ê¾÷¿¡ °¡Á®¿À´Â Áøº¸¸¦ »ó¡Çϸç, È¿À²È­¸¦ ÃËÁøÇÏ°í »ê¾÷ÀÇ ±Þ¼ÓÇÑ ÁøÈ­¸¦ Áö¿øÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¸· Å©·Î¸¶Åä±×·¡ÇÇ ½ÃÀåÀÇ º¯¼ö, µ¿Çâ, ¹üÀ§

Á¦4Àå ¸· Å©·Î¸¶Åä±×·¡ÇÇ ½ÃÀå : Á¦Ç° ºñÁî´Ï½º ºÐ¼®

Á¦5Àå ¸· Å©·Î¸¶Åä±×·¡ÇÇ ½ÃÀå : ¼ö¹ý ºñÁî´Ï½º ºÐ¼®

Á¦6Àå ¸· Å©·Î¸¶Åä±×·¡ÇÇ ½ÃÀå : ÃÖÁ¾ ¿ëµµ ºñÁî´Ï½º ºÐ¼®

Á¦7Àå ¸· Å©·Î¸¶Åä±×·¡ÇÇ ½ÃÀå : Áö¿ªº°, ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦8Àå °æÀï ±¸µµ

JHS
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Membrane Chromatography Market Trends:

The global membrane chromatography market size was estimated at USD 324.4 million in 2024 and is projected to grow at a CAGR of 16.0% from 2025 to 2030. The membrane chromatography market has experienced robust growth, primarily driven by the increasing demand for biopharmaceuticals and a heightened regulatory focus on cleaning validation for downstream purification processes. As biopharmaceutical purification becomes more scrutinized, the need for efficient, cost-effective solutions has led to a surge in membrane chromatography usage. This technology offers significant advantages over traditional column chromatography, including higher binding capacities and reduced buffer consumption, which are critical for optimizing biopharmaceutical production.

Scalability and ease of use further enhance the appeal of membrane chromatography, particularly for large biomolecules such as monoclonal antibodies and viral vectors, which are pivotal in therapeutic and vaccine production. The rise in demand for biologics is compounded by stringent regulatory standards for purity and safety, compelling companies in the bioprocessing industry to adopt advanced purification technologies such as membrane chromatography. This shift is supported by forecasts indicating that the biopharmaceutical market is expected to grow substantially, necessitating innovative purification methods to maintain quality and compliance.

Regulatory approvals for biopharmaceutical manufacturing are also fueling market growth. For instance, in April 2024, Boehringer Ingelheim Biopharmaceuticals China successfully passed pre-approval inspections conducted by both the European Medicines Agency and the U.S. Food and Drug Administration. Such achievements highlight the capacity of companies to meet regulatory demands, thereby encouraging further investments in purification technologies. As regulatory bodies increasingly endorse biopharmaceuticals aimed at addressing diverse medical conditions, the demand for membrane chromatography continues to rise.

In addition to regulatory factors, robust R&D expenditures in the biopharmaceutical sector are propelling market expansion. The International Federation of Pharmaceutical Manufacturers & Associations reported that the biopharmaceutical industry's annual R&D spending exceeds USD 202 billion, significantly outpacing sectors such as aerospace and defense by 7.3 times. This trend underlines the sector's commitment to innovation and underscores the growing number of product launches, including Waters Corporation's introduction of the XBridge Premier GTx BEH SEC columns in August 2023, tailored for gene therapy applications. Such innovations epitomize the advancements that membrane chromatography brings to the biopharmaceutical landscape, driving efficiency and supporting the industry's rapid evolution.

Global Membrane Chromatography Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global membrane chromatography market report based on product, technique, end use, and region:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Membrane Chromatography Market Variables, Trends, & Scope

Chapter 4. Membrane Chromatography Market: Product Business Analysis

Chapter 5. Membrane Chromatography Market: Route of Administration Business Analysis

Chapter 6. Membrane Chromatography Market: End Use Business Analysis

Chapter 7. Membrane Chromatography Market: Regional Estimates & Trend Analysis

Chapter 8. Competitive Landscape

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â